asymptomat
carrier
identifi
close
contact
prone
mildli
ill
hospit
howev
communic
period
could
three
week
commun
patient
could
develop
sever
ill
result
highlight
import
close
contact
trace
longitudin
surveil
via
viru
nucleic
acid
test
isol
recommend
continu
nucleic
acid
test
may
also
recommend
patient
discharg
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
limit
data
avail
asymptomat
infect
studi
aim
present
clinic
characterist
case
asymptomat
infect
screen
close
contact
show
transmiss
potenti
asymptomat
viru
carrier
epidemiolog
investig
conduct
among
close
contact
patient
suspect
patient
nanj
jiangsu
provinc
china
jan
feb
clinic
commun
asymptomat
carrier
laboratoryconfirm
posit
viru
test
nucleic
acid
pharyng
swab
sampl
clinic
record
laboratori
assess
chest
ct
scan
review
none
asymptomat
case
present
obviou
symptom
nucleic
acid
screen
five
case
develop
symptom
fever
cough
fatigu
etc
hospit
twelv
case
show
typic
ct
imag
groundglass
chest
present
stripe
shadow
lung
remain
case
show
normal
ct
imag
symptom
hospit
case
younger
median
age
year
p
rest
none
case
develop
sever
pneumonia
die
median
communic
period
defin
interv
first
day
posit
nucleic
acid
test
first
day
continu
neg
test
day
day
among
asymptomat
case
epidemiolog
investig
observ
typic
asymptomat
transmiss
cohabit
famili
member
even
caus
sever
pneumonia
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
genet
analysi
reveal
viru
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
unlik
sarscov
transmiss
occur
prodrom
period
infect
mildli
ill
carri
usual
activ
contribut
spread
infect
accord
report
diamond
princess
among
test
travel
asymptomat
individu
posit
viru
februari
indic
larg
number
asymptomat
carrier
mild
patient
remain
undiscov
commun
crucial
identifi
isol
asymptomat
carrier
mild
patient
order
contain
outbreak
later
stage
conduct
epidemiolog
investig
among
close
contact
patient
nanj
jiangsu
provinc
china
identifi
asymptomat
carrier
sought
delin
clinic
characterist
transmiss
potenti
asymptomat
infect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
screeningidentifi
asymptomat
case
nanj
admit
second
hospit
nanj
hospit
admit
patient
citi
jan
feb
retrospect
review
document
epidemiolog
investig
medic
record
asymptomat
carrier
screen
close
contact
clinic
commun
close
contact
defin
cohabit
famili
member
patient
suspect
patient
individu
expos
patient
within
meter
hour
within
day
symptom
onset
patient
nucleic
acid
test
perform
day
contact
track
studi
review
approv
medic
ethic
committe
second
hospit
nanj
approv
number
written
inform
consent
obtain
enrol
patient
upon
admiss
detail
contact
histori
case
collect
includ
travel
histori
hubei
datetim
suspect
contact
symptom
onset
contact
confirm
patient
inform
famili
member
histori
smoke
coexist
disord
also
collect
case
comput
tomographi
ct
perform
upon
admiss
laboratori
assess
includ
whole
blood
count
blood
chemistri
coagul
test
liver
renal
function
electrolyt
creactiv
protein
procalcitonin
lactat
dehydrogenas
creatin
kinas
pharyng
swab
specimen
collect
admiss
day
everi
day
thereaft
viru
test
sampl
process
simultan
depart
clinic
laboratori
second
hospit
nanj
symptom
present
case
hospit
record
studi
includ
fever
cough
nasal
congest
dizzi
fatigu
arthralgia
etc
viru
clearanc
defin
continu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
neg
nucleic
acid
test
pharyng
swab
specimen
describ
test
use
qrtpcr
kit
bgi
genom
beij
china
recommend
chines
center
diseas
control
prevent
cdc
follow
guidelin
continu
variabl
express
median
interquartil
rang
iqr
categor
variabl
summar
count
percentag
categori
wilcoxon
ranksum
test
appli
continu
variabl
fisher
exact
test
use
categor
variabl
analys
conduct
statas
fund
agenc
particip
studi
design
data
collect
data
analysi
write
report
correspond
author
respons
aspect
studi
ensur
issu
relat
accuraci
integr
part
work
properli
investig
resolv
final
version
approv
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
author
demograph
characterist
asymptomat
case
shown
tabl
none
case
healthcar
worker
histori
recent
travel
hubei
case
resid
hubei
mark
blue
arrow
five
case
case
figur
symptom
hospit
five
case
develop
fever
without
chill
bodi
temperatur
fluctuat
none
present
high
fever
bodi
temperatur
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
symptom
caus
admiss
case
chest
ct
scan
twelv
case
show
typic
find
chest
ct
imag
groundglass
patchi
shadow
lung
figur
five
case
show
stripe
shadow
lung
atyp
imag
find
ct
scan
rest
case
show
normal
imag
four
case
lymphopenia
cellsl
admiss
leukopenia
also
observ
case
elev
level
alanin
aminotransferas
aspart
aminotransferas
creatin
kinas
creactiv
protein
ddimer
uncommon
tabl
hospit
case
case
develop
leukopenia
seven
case
present
elev
level
serum
lactos
dehydrogenas
among
accompani
increas
level
creactiv
protein
figur
antivir
therapi
given
case
initi
therapi
one
case
also
receiv
antibiot
therapi
antifung
therapi
plu
immunoglobin
therapi
immunoglobin
therapi
also
given
case
case
treat
interferon
atom
none
case
develop
sever
pneumonia
requir
system
corticosteroid
treatment
mechan
ventil
admiss
icu
none
die
tabl
feb
total
case
viru
clear
continu
neg
nucleic
acid
test
among
case
discharg
hospit
rest
kept
hospit
observ
six
case
case
nucleic
acid
test
revers
posit
one
neg
result
particular
concern
show
posit
even
continu
neg
nucleic
acid
test
five
case
case
viru
clear
within
short
time
communic
period
defin
interv
first
day
posit
nucleic
acid
test
first
day
continu
neg
test
rang
day
median
day
iqr
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
day
figur
tabl
due
censor
data
case
indetermin
date
exact
first
infect
communic
period
underestim
found
case
normal
ct
imag
symptom
hospit
compar
case
case
younger
median
p
tabl
differ
characterist
group
possibl
due
limit
sampl
size
blood
test
case
show
obviou
abnorm
median
communic
period
patient
day
iqr
review
medic
record
epidemiolog
histori
case
famili
member
admit
hospit
confirm
suspect
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
case
symptom
remain
posit
viru
till
feb
indic
communic
period
could
long
day
jan
feb
among
infect
famili
member
rel
develop
sever
pneumonia
admit
icu
feb
rel
demonstr
clearanc
viru
feb
brief
case
asymptomat
carrier
transmit
viru
cohabit
famili
member
infect
individu
develop
sever
pneumonia
admit
icu
present
studi
provid
epidemiolog
clinic
data
asymptomat
infect
identifi
screen
close
contact
nanj
jiangsu
provinc
asymptomat
case
mildli
ill
compar
previous
report
wuhan
hubei
none
case
develop
sever
pneumonia
case
show
typic
symptom
hospit
similar
previou
studi
fever
cough
fatigu
main
symptom
lymphopenia
leukopenia
previous
associ
diseas
sever
uncommon
asymptomat
case
present
studi
interestingli
found
young
case
year
old
prone
asymptomat
even
hospit
normal
ct
imag
partial
suggest
nucleic
acid
test
would
crucial
identifi
asymptomat
infect
young
close
contact
notabl
provid
evid
transmiss
asymptomat
infector
close
contact
led
sever
pneumonia
find
indic
asymptomat
carrier
result
persontoperson
transmiss
consid
sourc
infect
also
implic
report
diamond
princess
larg
number
asymptomat
mild
patient
might
hide
commun
therefor
great
public
health
signific
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
strictli
monitor
close
contact
via
multipl
nucleic
acid
screen
contain
potenti
outbreak
particular
sinc
massiv
movement
return
work
place
school
progress
activ
contact
trace
strict
health
monitor
remain
import
strategi
china
worldwid
guidanc
selfprotect
activ
isol
close
contact
either
home
central
continu
highlight
isol
multipl
viru
nucleic
acid
detect
also
recommend
discharg
patient
studi
conduct
nanj
citi
adequ
medic
public
health
intervent
includ
case
identifi
systemat
screen
close
contact
patient
suspect
patient
clinic
commun
asymptomat
carrier
admit
treat
second
hospit
nanj
therefor
studi
popul
strong
repres
whole
citi
collect
contact
histori
follow
longitudin
nucleic
acid
test
close
contact
hospit
provid
rel
reliabl
communic
period
asymptomat
case
howev
notabl
real
communic
period
longer
calcul
due
censor
data
patient
indetermin
date
exact
first
infect
studi
limit
small
sampl
size
lack
data
nucleic
acid
test
diagnosi
date
largescal
multicent
studi
need
verifi
find
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
